Applicability of Uroflowmetry in Children with Cerebral Palsy
What is the Difference in the Applicability of the Uroflowmetry Between Children with Cerebral Palsy (CP) with Lower Urinary Tract Symptoms (LUTS) and Without Lower Urinary Tract Symptoms (LUTS)
1 other identifier
interventional
56
1 country
1
Brief Summary
Until now, the use of invasive urodynamics with use of catheters is still the gold standard for lower urinary tract evaluation in subjects with CP. This suggests a psychological and physical impact of invasive urodynamics in subjects with CP and further demonstrates the need to avoid standard use of invasive urodynamics in children and adults with CP. The current study will evaluate usefulness of uroflowmetry, correlation between uroflowmetry parameters and different lower urinary tract symptoms will be investigated. Secondly, results of uroflowmetry indicating possible vulnerability of the upper urinary tract will be defined.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 16, 2021
CompletedFirst Posted
Study publicly available on registry
August 23, 2021
CompletedStudy Start
First participant enrolled
October 14, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2023
CompletedSeptember 19, 2024
September 1, 2024
1.7 years
August 16, 2021
September 5, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Amount of pathological uroflow patterns - Qualitative assessment
Interpretation by pediatric urologist following ICCS classification Measured during uroflowmetry
During cross-sectional testing
Amount of pathological uroflow patterns - Quantitative assessment
Interpretation using Flow index methodology Measured during uroflowmetry
During cross-sectional testing
Maximal flow
Measured during uroflowmetry Qmax (mililitres/seconds
During cross-sectional testing
Secondary Outcomes (3)
Influencing factors for uroflow measurement
During cross-sectional testing
Voided volume
During cross-sectional testing
Post void residual urine
During cross-sectional testing
Study Arms (2)
Standard toilet chair (hip angle 90°)
EXPERIMENTALuroflow measurement with subsequent post void residual measurement, conducted on a standard toilet chair.
Toilet chair with decreased hip angle
EXPERIMENTALuroflow measurement with subsequent post void residual measurement, conducted on a toilet chair with decreased hip angle.
Interventions
Non-invasive urodynamic measurement wireless uroflowmeter UROCAP™ IV, Goby System Laborie
Ultrasound of post void residual urine bladderscan CUBEscan BioCon 700
Eligibility Criteria
You may qualify if:
- Diagnosis of cerebral palsy
- Dutch or French speaking child and parent
You may not qualify if:
- History of urological surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Ghentlead
- University Ghentcollaborator
Study Sites (1)
Ghent University Hospital
Ghent, Flanders, 9000, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bieke Samijn, dr.
Ghent University Hospital/Ghent University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 16, 2021
First Posted
August 23, 2021
Study Start
October 14, 2021
Primary Completion
June 30, 2023
Study Completion
June 30, 2023
Last Updated
September 19, 2024
Record last verified: 2024-09